2.Reyes A, Astiazaran JA, Chavez CC, Jaramillo F and Saliba MJ. Burns treated with and without heparin: controlled use in a thermal disaster. Annals of Burns and Fire Disasters. 2001;14(4):183-191.

3. Glucosaminoglycans In Burns: Multi-Center Update: Proceedings: 10th CONGRESS OF INTERNATIONAL SOCIETY FOR BURN INJURIES, Jerusalem, Israel, Nov 1-5, 1998: Abstracts of presentations: Saliba, MJ Jr., La Jolla, CA USA. p 10,11,20,34,70; Mangus DJ. Chico, CA USA. p 20; Ramakrishnan KM., Madras, INDIA. p 11,11, 21; Traber DL., Galveston, TX, USA p 11,34; Dmitreinko, O., St. Petersburg, RUSSIA p 11; Hruba, J. Prague, Czech Republic p 10. Hansbrough JF. San Diego, CA USA p 10.

4. In Proceedings: THE EFFECTS OF HEPARIN IN THE TREATMENT OF BURNS: INTERNATIONAL MEETING. Feb 24-27 1994. San Diego, CA, USA. Editor: Dr Saliba. Saliba MJ Jr, p3-8,15-68; Green BE, p9-14; Ramakrishnan KM, p69-73,84-93,123-126; Cox CS, p74-82; Hansbrough JF, Abst p28; Traber L, p94-122; Mangus DJ, p127+19p; Konigova R, and Hubra J, p128-131. Reprints: Tel/Fax:USA + 858 454 2686 or write: Michael J. Saliba Jr., MD. 5582 Thunderbird Lane, La Jolla, CA 92037 USA

5. Rigdon RH, and Wilson H. Capillary permeability and inflammation in rabbits given heparin. Arch Surg. 1941;43:64-73.

6. Aldrich EM. Studies in burns II. Observations on a vasoconstrictor substance in lymph from a burned area. Surgery. 1944;15:908-912.

7. Aldrich EM. The effect of heparin on the circulating blood plasma and proteins in experimental burns. Surgery. 1949;25:686-.

8. McCleary RS, Schaffarzick WH, and Light RH. An experimental study of the effect of heparin on local pathology of burns Surgery. 1949;26:548-564.

9. Parsons R. Jr, Aldrich EM, and Lehman RP. Studies on burns: effect of heparin and gravity on tissue loss resulting from third degree burns. Surg Gyn Obstet. 1950;90:722-.

10. Elrod PD, McCleary RS, and Ball OT. An experimental study of the effect of heparin on survival time following lethal burns. Surg Gyn Obstet. 1951;92:35-42.

11. Green BE, and Artz CP. An appraisal of heparin in burns: Experimental study. Surgical Forum. 1959;10:343-. And Reference 2:pp9-14.

12. Brooks F, Dragstedt LR, Warner L, and Knisely MH. Sludged blood following severe themal burns. Arch Surg. 1950;61:387-418.

13. Branemark P, Breine V, Joshi M, Urbaschek B. Microvascular pathophysiology of burned tissue. Ann NY Acad Sci. 1964;150:474-.

14. Keller R. Zor bindung von histamin und serotonin in den mastzellen. Arzneimittel- Forsch. 1958;8:390-

15. Majno WW, and Palade GE. Studies on inflammation: 1. The effect of histamine and serotonin on vascular permeability. J Biophys & Biochem Cytol. 1961;11:571-605.

16. Kobayasch Y. Histamin binding by heparin. Biochem & Biophy. 1962;96:20-27.

17. Dolowitz DA, and Dougherty TF. The use of heparin as an antiinflammatory agent. Laryngoscope. 1960;70:873-.

18. Doughtery TF, and Dolowitz DA. Physiologic actions of heparin not related to blood clotting. Am J Cardiology. 1964;14:18-.

19. Boyle JP, Smart RH, and Shirley JK. Heparin in treatment of chronic obstructive bronchopulmonary disease. Am J Cardiology. 1964;14:25-.

20. Ley K, Cerrito M, Arfors KE. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol. 1991;260;H1667-H1673.

21. Saliba MJ Jr. Heparin in the treatment of burns. JAMA. 1967;200:650.

22. Saliba MJ Jr. Heparin efficacy in burns. II. Human thermal burn treatment with large doses of topical and parenteral heparin. Aerospace Medicine. 1970;41:1302-1312.

23. Saliba MJ Jr, Dempsey WC, and Kruggel JL. Large burns in humans, treatment with heparin. JAMA. 1973;225:261-269.

24. Saliba MJ Jr. Heparin, nature's own burn remedy? Emergency Medicine. 1973;106:111-.

25. Saliba MJ Jr and Saliba RJ. Heparin in burns: dose related and dose dependent effects. Thrombos Diasthes Haemorrh (Stuttig). 1974;33:113-.

26. Saliba MJ Jr: The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chirurgiae Plasticae 1997;39:13-16.

27. Saliba MJ Jr, Covell JM, Bloor CM. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog. Am J Cardiol. 1976;37:599-604.

28. Saliba, MJ Jr, Kuzman WJ, and Miller M. Effect of heparin in anticoagulant doses on the ECG and cardiac enzymes in patients with acute myocardial infarction. Am J Cardiol. 1976;37:604-607.

29. Saliba MJ Jr, and Griner L.A: Heparin efficacy in burns. I. Significant early modification of experimental third-degree guinea pig thermal burn. Aerospace Med. 1970;41:179-.

30. Chemical mediators of inflammation. In: Cotran RS, Robbins SL, and Kumar V, eds Robbins Pathologic Basis of Disease 5th Ed. Philadelphia, PA Hardcourt Brace;1994:65.

31. Carr J: The anti-inflammatory action of heparin: heparin as an antagonist to histamine, bradykinin, and prostaglandin E1. Thromb Res. 1979;16:507-516.

32. Gregrius FK, Rand RW: Scanning electron microscopy of the rat common carotid artery: III. Heparin effects on platelets. Surgery. 1976;79:584-589.

33. Shanberge JN, Kambayashi J, Nakagawa M. The interaction of platelets with a tritium-labeled heparin. Thrombos Res. 1976;9:595-609.

34. Rent R, Nyirman RRR, Fiedel BA, Gewutz H. Potentiation of C1 esterase inhibitor activity by heparin. Clin Exp Immunol. 1976;23:264-271.

35. Hiebert LM, Lui JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Arteriosclerosis. 1990;83:37-51.

36. Lantz M, Thysell H, Nilsson E, Olsson I. On the binding of tumor-necrosis-factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest. 1991;88:2026-2031.

37. Lider O, Bahav E, Mekori YA, et al. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treating animals with low doses of heparin. J Clin Invest. 1989;83:752-766.

38. Robinson DS, Harris PM. The production of lipolytic activity in the circulation of the hind limb in response to heparin. Q J Exp Physiol. 1955;44:80-90.

39. Griffin MP, Gore DC, Zwischenberger JB, et al. Does heparin improve survival in experimental porcine gram-negative shock. Circ Shock. 1990;31:343-349.

40. Wright JG, Massop DW, Furst JG, Durham JR, Smead WL. Pre-ischemic heparinization decreases rat skeletal muscle reperfusion injury. J Cardiovasc Surg 32(sp):II.Ab

41. Sternberg, WC III, Makhoul RG, and Adelman B. Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J Vasc Surg. 1993;17:318-327.

42. Travis MJ MD, Taira M, Jaques, Bartlett RH MD. Heparin in experimental full-thickness burns: a comparative study. Proceedings Am Burn Assoc 1978 p10:(ab48

43. Mangus DJ, Falces E, Gilchrist DR. Heparinization and the use of culture-specific antibiotic liquids in the treatment of large burns. In Proceedings: Ref 2;p127+19pSuppl.

44. Ramakrishnan KM, and Jayaraman V. Clinical uses of heparin in burns in Madras, India. In: Proceedings EFFECTS OF HEPARIN IN BURNS. INTERNATIONAL MEETING. San Diego, CA USA 1994;p 69-73. Dr Saliba, Editor Tel/Fax+ 858 454 2686.

45. Ramarkrishnan KM, and Jayaraman V. Heparin effects in burn pathophysiology. In: Proceedings. See Ref 46. 1994;p123-126. Dr Saliba, Editor Tel/Fax: 858 454 2686

46. Ramakrishnan KM, and Jayaraman V. Beneficial effects of topical heparin in burn wound healing. In: Proceedings. Ref 2. 1994;p84-93. And Ref 1. 1998;p11.

47. Ramakrishnan KM: Burn reduction in burn facial oedema, burn extension, and grafts in burned humans using heparin administered parenterally. In Proceedings. Ref 2 1994;p87-93 and Ref 1 1998:p11.

48. Ramakrishnan KM, Babu M. and Ramachandran K. Effects of heparin on collagen in burns. The International Transaction of the Plastic and Reconstructive Surgery Congress. Montreal Canada. 1984.

49. Ramakrishnan KM, Babu M, and Ramachandran K. Altered pattern of collagen synthesis in burns treated with both systemic and local heparin use that improved burn care. In Proceedings. Ref 2 1994;p124-129. And Ref 1 1998;p21. Contact: K. Mathangi Ramakrishnan, MB. FRCS. M.Ch. D.Sc., Director, Pediatric Burn ICU & Plastic Surg Chief, Childs Trust Hospital, Madras India. Fax: + 91 44 823 4044.

50. Dmitrienko O., Bagnenko S., Kuzulin D., Ankin Tu., Takimov D. Experiences with heparin care in burned patients: with topical and parenteral use. St Petersburg Russia. 10th ISBI (See Ref 1.) 1998:p11. Contact: Dr Dmitrienko Tel/Fax: + 7 812 314 2233.

51. Saliba MJ, Bonillo A, and Zayas C. Initial heparin use topically and parenterally in burned children in El Salvador. 1999: Preprint.

52. Bonillo A, Saravia M, Zayas C, and Saliba M. Heparin effects by parenteral, topical, and inhalation in human burns in El Salvador. 1999: Preprint.

53. Azizkhlan, et. al. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med. 1980;152:931-.

54. Macaig T et al. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science. 1984;225:932-.

55. Folkman J. Weisz PB, Joullie MM, Li WW, Ewing WR. Control of angiogenesis with synthetic heparin substitutes. Science 1989;243:1490-1493.

56. Zapata-Sirvant RL, Hansbrough JF, Greenleaf GE, et al. Reduction of bacterial translocation and intestinal structure alterations by heparin in a murine burn injury model. The Journal of Trauma. 1994;36:1-6. And in Ref 1 and 2 of this review.

57. Gianotti L, Alexander JW, Fukushima R, Pyles T. Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate. Am J Surg. 1993;165:195-200.

58. Hruba J. Prevention of stress bleeding in burn medicine. Using heparin and sucralfate. In Proceedings Ref 2. 1994:p127-131. And in Ref 1.

59. Ferrao AV and Mason RM: The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts. Biochemica et Biophysica Acta 1993;1180:225-230.

60. McCarthy DW; Downing MT; Brigstock DR; Luquette MH; Brown KD; Abad MS; Gesner GE. Production of heparin-binding epidermal growth factor-like growth factor at sites of thermal injury in pediatric patients. J Investigative Dermatology. 106:49-56.

61. Ehrlich H.Rr; Griswold TR; Rajaratanam JBM: Studies on vascular smooth muscle cells and dermal fibroblast in collagen matrices. effects of heparin. Exp Cell Res, 1986;164:154-162.

62. Cox CS, Zwischenberger JB, Traber DL, et al. Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in ovine model. Surg Gynecol Obstet. 1993;76:339-349.

63. Brown M, Desai M, Traber L.D., et al. Dimethylsulfoxide with heparin in treatment of smoke inhalation injury. J Burn Care Rehabil. 9:22-25. And Circ Shock 1988;9:22-25.

64. Desai MH MD, Mlcak RRT RCP, Richardson RCP RRT, et al. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/acetylcystine therapy. J Burn Care Rehabil. 1998;19:(3)210-13.

Heparinised Collagen Membrane